Cargando…
Prognostic value of PD-L1 in esophageal squamous cell carcinoma: a meta-analysis
Accumulated evidence has shown that the programmed cell death receptor 1/programmed cell death receptor 1 ligand 1 (PD-1/PD-L1) pathway is a promising therapeutic target for cancer immunotherapy. However, the association between PD-L1 and esophageal squamous cell carcinoma (ESCC) patient survival re...
Autores principales: | Guo, Wei, Wang, Pan, Li, Ning, Shao, Fei, Zhang, Hao, Yang, Zhenlin, Li, Renda, Gao, Yibo, He, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862626/ https://www.ncbi.nlm.nih.gov/pubmed/29568405 http://dx.doi.org/10.18632/oncotarget.23810 |
Ejemplares similares
-
Prognostic value of circulating tumor cells in esophageal cancer
por: Xu, Hai-Tao, et al.
Publicado: (2017) -
Prognostic and clinicopathological value of Twist expression in esophageal cancer: A meta-analysis
por: Song, Wen-Peng, et al.
Publicado: (2022) -
Prognostic and Clinicopathologic Significance of Neutrophil-to-Lymphocyte Ratio in Esophageal Cancer: An Update Meta-Analysis
por: Li, Binfeng, et al.
Publicado: (2022) -
The prognostic value of HPV combined p16 status in patients with anal squamous cell carcinoma: a meta-analysis
por: Sun, Guorui, et al.
Publicado: (2017) -
Effectiveness of anti-PD-1/PD-L1 antibodies in urothelial carcinoma patients with different PD-L1 expression levels: a meta-analysis
por: Liu, Junqi, et al.
Publicado: (2018)